Enrolling by Invitation
A Long-term Follow-up Study of Participants Who Received Delandistrogene Moxeparvovec (SRP-9001) in a Previous Clinical Study
NCT05967351
- Conditions
- Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Duchenne Muscular Dystrophy, Genetic Diseases, Inborn, +8 more
- Locations
-
- Arkansas Children's Hospital Little Rock, Arkansas, United States
- UCLA Medical Center Los Angeles, California, United States
- Lucile Packard Children's Hospital Stanford (LPCH) Palo Alto, California, United States
- University of California, Davis Sacramento, California, United States